NORTHFIELD, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LEUKEMIA RESEARCH FOUNDATION, founded in 1951, is a community nonprofit in the Medical Research sector that reported $2.5M in total revenue in fiscal year 2023. Revenue fell 40% from the prior year — a significant decline worth monitoring.
TO CURE LEUKEMIA BY FUNDING INNOVATIVE RESEARCH, AND TO SUPPORT PATIENTS AND FAMILIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,495,610 | $4,193,244 | -0.4% |
| Expenses | $2,610,071 | $3,582,485 | -0.3% |
| Net Income | $-114,461 | $610,759 | -1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BLAKE BRANDWEIN | PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| GERALD BRIN | TREASURER | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| PATTY MIX | SECRETARY | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| ROBERT GRABEMANN | GENERAL COUNSEL | 0.50 |
Director
|
$0 | $0 | $0 |
| TAMAR UZIEL | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| JAIME MORAN | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| JOE GARBARSKI | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| TODD HOLMES | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| FRANK MARTINEZ | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| LARRY MIX | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| RANDI SCHULLO | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| STEVE WILENSKY | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| SAVYON AMIT | VICE PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| RONG CHEN | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| KEVIN RADELET | EXECUTIVE DIRECTOR | 37.50 |
Officer
|
$153,786 | $19,349 | $173,135 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $2,495,610 | $2,610,071 | $6,882,073 | $-114,461 |
| 2023 | $4,193,244 | $3,582,485 | $6,864,748 | $610,759 |
| 2022 | $2,910,174 | $2,501,059 | $5,035,074 | $409,115 |
| 2021 | $2,562,072 | $2,472,196 | $4,522,929 | $89,876 |
| 2020 | $2,620,594 | $2,460,482 | $4,154,136 | $160,112 |
| 2019 | $2,386,635 | $2,371,139 | $3,878,638 | $15,496 |
Compare LEUKEMIA RESEARCH FOUNDATION with other nonprofits in Illinois and across the country.